How have hedgies been trading Stemline Therapeutics Inc (NASDAQ:STML)? At Q2's end, a total of 17 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -15% from the ...

CEO of Stemline Therapeutics Inc (30-Year Financial, Insider Trades) Ivan Bergstein (insider trades) sold 35,010 shares of STML on 08/14/2019 at an average price of $14.73 a share. Continue reading ...